Search filters

Filters
Clear All

Phase

  • 1
  • 3
  • 4
  • 1
  • 1
  • 3

Found 4 Vascular-Diseases trials

A listing of Vascular-Diseases medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

The OHART Study

18-99 years
All genders
The purpose of this study is to investigate different oral and systemic problems including dental carries, periodontal disease, dry mouth, high cholesterol, diabetes, heart disease, and osteoporosis, observed in patients living with HIV on antiretroviral therapy. 
 Continuation of the nuMoM2b Heart Health Study

Continuation of the nuMoM2b Heart Health Study (nuMoM2b-HHS2)

18-99 years
Female
Interventional
The nuMoM2b Heart Health Study (nuMoM2b-HHS) has followed a demographically diverse cohort of women enrolled and richly phenotyped during their first pregnancy, with data and biospecimens prospectively collected for up to 7 years thereafter. The overarching scientific goal of this study is to define the relationship between adverse pregnancy outcomes …
 STRIDE Study : The Effects of semaglutide on functional capacity in pith type 2 diabetes and peripheral arterial disease

STRIDE Study : The Effects of semaglutide on functional capacity in pith type 2 diabetes and peripheral arterial disease

18-99 years
All genders
Phase 3
This is a 52 week, randomized, double-blind, placebo-controlled trial comparing semaglutide 1 mg versus placebo both added to standard of care and administered once weekly in subjects with Type 2 Diabetes Mellitus with Intermittent Claudication.

Evaluation of accelerated sampling techniques for vessel wall imaging

All genders
Specific Aim 1: To image the intracranial artery vessel walls (brain), we will evaluate and compare scans acquired using standard-of-care T1 SPACE and T1 MPRAGE sequences with novel accelerated pulse sequences in patients with suspected intracranial vasculopathy. Specific Aim 2: To image the extracranial artery vessel walls (neck). We will …